As of Apr 23
| -0.55 / -1.39%|
The 7 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 62.00, with a high estimate of 79.00 and a low estimate of 48.00. The median estimate represents a +58.41% increase from the last price of 39.14.
The current consensus among 7 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.